AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

Sulfamethoxazole BP/ Trimethoprim BP

10 registrations across 1 African market— 10 active

Markets with Sulfamethoxazole BP/ Trimethoprim BP

Recent registrations

Brand / ProductMarketHolderStatusExpires
T.S. SOL SOLUTION (TRIMETHOPRIM+SULFAMETHOXAZOLE -20MG+80MG)🇬🇭GhanaDOPHARMA B.V. ZALMWEG 24-4941 VX, THE NETHERLANDSactiveDec 2029
T.S. SOL SOLUTION (TRIMETHOPRIM+SULFAMETHOXAZOLE -20MG+80MG)🇬🇭GhanaDOPHARMA B.V. ZALMWEG 24-4941 VX, THE NETHERLANDSactiveDec 2029
CONTRI-480 TABLETS🇬🇭GhanaactiveOct 2029
CONTRI-480 TABLETS🇬🇭GhanaactiveOct 2029
SEPTREX SUSPENSION🇬🇭GhanaactiveSept 2029
SEPTREX SUSPENSION🇬🇭GhanaactiveSept 2029
CO-TRIMOXAZOLE TABLETS🇬🇭GhanaactiveAug 2029
CO-TRIMOXAZOLE TABLETS🇬🇭GhanaactiveAug 2029
CO-TRIMOXAZOLE TABLETS (Each tablet contains Sulfamethoxazole BP/ Trimethoprim BP 340mg/50mg)🇬🇭GhanaactiveDec 2028
CO-TRIMOXAZOLE TABLETS (Each tablet contains Sulfamethoxazole BP/ Trimethoprim BP 340mg/50mg)🇬🇭GhanaactiveDec 2028

Sulfamethoxazole BP/ Trimethoprim BP in Africa — Regulatory Overview

Sulfamethoxazole BP/ Trimethoprim BP is registered across 1 African markets with 10 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Ghana. AfricaRegulatory refreshes this data daily from official government sources.

Of the 10 registrations, 10 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.